Hepatitis C virus infection as a risk factor for Parkinson disease
A nationwide cohort study
Citation Manager Formats
Make Comment
See Comments

This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
Abstract
Objective: To determine whether hepatitis C virus (HCV) infection is a risk factor for developing Parkinson disease (PD).
Methods: This nationwide population-based cohort study was based on data obtained from a dataset of the Taiwan National Health Insurance Research Database for the period 2000 to 2010. A total of 49,967 patients with viral hepatitis were included for analysis. Furthermore, 199,868 people without viral hepatitis were included for comparisons. Patients with viral hepatitis were further grouped into 3 cohorts: hepatitis B virus (HBV) infection, HCV infection, and HBV-HCV coinfection. In each cohort, we calculated the incidence of developing PD. A Cox proportional hazards model was applied to estimate the risk of developing PD in terms of hazard ratios (HRs) and 95% confidence intervals (CIs).
Results: The crude HRs for developing PD was 0.66 (95% CI = 0.55–0.80) for HBV infection, 2.50 (95% CI = 2.07–3.02) for HCV infection, and 1.28 (95% CI = 0.88–1.85) for HBV-HCV coinfection. The association between HCV and PD remained statistically significant after adjustments for age, sex, and comorbidities (adjusted HR = 1.29, 95% CI = 1.06–1.56).
Conclusions: We conducted a large nationwide population-based study and found that patients with HCV exhibit a significantly increased risk of developing PD.
GLOSSARY
- BBB=
- blood–brain barrier;
- CI=
- confidence interval;
- HBV=
- hepatitis B virus;
- HCV=
- hepatitis C virus;
- HR=
- hazard ratio;
- ICD-9-CM=
- International Classification of Diseases, Ninth Revision, Clinical Modification;
- LHID=
- Longitudinal Health Insurance Database;
- NHI=
- National Health Insurance;
- NHIP=
- National Health Insurance Program;
- NHIRD=
- National Health Insurance Research Database;
- PD=
- Parkinson disease;
- PS=
- propensity score
Footnotes
Go to Neurology.org for full disclosures. Funding information and disclosures deemed relevant by the authors, if any, are provided at the end of the article.
↵* These authors contributed equally to this work.
Supplemental data at Neurology.org
- Received September 3, 2015.
- Accepted in final form November 4, 2015.
- © 2015 American Academy of Neurology
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
For assistance, please contact:
AAN Members (800) 879-1960 or (612) 928-6000 (International)
Non-AAN Member subscribers (800) 638-3030 or (301) 223-2300 option 3, select 1 (international)
Sign Up
Information on how to subscribe to Neurology and Neurology: Clinical Practice can be found here
Purchase
Individual access to articles is available through the Add to Cart option on the article page. Access for 1 day (from the computer you are currently using) is US$ 39.00. Pay-per-view content is for the use of the payee only, and content may not be further distributed by print or electronic means. The payee may view, download, and/or print the article for his/her personal, scholarly, research, and educational use. Distributing copies (electronic or otherwise) of the article is not allowed.
Letters: Rapid online correspondence
- Author Response to Boyd et al.
- Chia-Hung Kao, Professor, National Taiwan University HospitalD10040@mail.cmuh.org.tw
- Hsin-Hsi Tsai
Submitted April 01, 2016 - Hepatitis C virus infection and Parkinson disease: Possible role for interferon
- Jame T. Boyd, Department of Neurological Sciences, University of Vermont College of Medicinejames.boyd@uvmhealth.org
- Kirk J. Wangensteen, Philadelphia, PA; Edward L. Krawitt, Burlington, VT; Robert W. Hamill, Burlington, VT
Submitted March 24, 2016
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
More Online
Dr. David E. Vaillancourt and Dr. Shannon Y. Chiu
► Watch
Topics Discussed
Alert Me
Recommended articles
-
WriteClick® Editor's Choice
Hepatitis C virus infection as a risk factor for Parkinson disease: A nationwide cohort studyJames T. Boyd, Chia-Hung Kao, Kirk J. Wangensteen et al.Neurology, July 18, 2016 -
Article
Viral hepatitis and Parkinson diseaseA national record-linkage studyJulia Pakpoor, Alastair Noyce, Raph Goldacre et al.Neurology, March 29, 2017 -
Article
Hepatitis C virus infection in inclusion body myositisA case-control studyAkinori Uruha, Satoru Noguchi, Yukiko K. Hayashi et al.Neurology, December 18, 2015 -
Editorial
Viral hepatitis and the risk of Parkinson diseaseJulián Benito-León et al.Neurology, March 29, 2017